Adults with plaque PsO who received continuous icotrokinra had superior efficacy outcomes when compared with those who switched to placebo.

Topical ruxolitinib cream 1.5% for 24 weeks was significantly associated with disease improvement among patients with prurigo nodularis.

Delgocitinib cream 20mg/g significantly improves the sign and symptoms of chronic hand eczema among adolescent patients compared with vehicle cream.

High doses of temtokibart — including 600 mg, 450 mg, and 300 mg — contributed to significant improvements in disease severity in patients with AD.

Levels of systemic inflammatory markers were reduced following 16 weeks of secukinumab treatment in patients with moderate to severe HS.

Presenting research from the annual meeting of the European Academy of Dermatology and Venereology. Dermatology Advisor, a trusted source of medical news and feature content for healthcare providers, ...

HealthDay News — The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over two seasons, according to a study published online Sept. 3 in JAMA Network ...

Theoretically ending Ryan White services for 5 years was estimated to result in 75,436 additional HIV infections.

The time to onset of action was fastest with IL-17 inhibitors, followed by IL-23, IL-12/23, then PDE-4 and JAK inhibitors for ...

A child in Los Angeles County subacute sclerosing panencephalitis, a complication of measles that affects 1 in 600 infants.

The FDA is regulating direct-to-consumer drug advertisements to ensure "fair balance" of information on pharmaceutical products.

The United States contributed more than half of global public and philanthropic cancer research funding between 2016 and 2023.